ArticleMolecular oncology2023

Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X

Manuel Beltrán-Visiedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.